SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-079140
Filing Date
2023-07-07
Accepted
2023-07-07 16:28:57
Documents
13
Period of Report
2023-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2320816d1_8k.htm   iXBRL 8-K 25384
2 EXHIBIT 10.1 tm2320816d1_ex10-1.htm EX-10.1 40441
  Complete submission text file 0001104659-23-079140.txt   244768

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ocul-20230630.xsd EX-101.SCH 3006
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocul-20230630_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocul-20230630_pre.xml EX-101.PRE 22353
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2320816d1_8k_htm.xml XML 3213
Mailing Address 24 CROSBY DRIVE BEDFORD MA 01730
Business Address 24 CROSBY DRIVE BEDFORD MA 01730 781-895-3235
OCULAR THERAPEUTIX, INC (Filer) CIK: 0001393434 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36554 | Film No.: 231077083
SIC: 2834 Pharmaceutical Preparations